...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Tweet from Prof Kausik Ray

IMO, premature for a Phase 4. Apabetalone is not approved for any indication yet and has failed to meet the primary endpoint in its past 2 major trials (Phase 2 ASSURE, Phase 3 BETonMACE).

BDAZ

Share
New Message
Please login to post a reply